These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 32654613)
21. Influence of Lipid Excipients on Platelet Function and the Pharmacodynamic Effects of Aspirin. Schneider DJ; Taatjes-Sommer HS; Prats J; Deliargyris EN J Cardiovasc Pharmacol; 2021 Aug; 78(2):297-301. PubMed ID: 33657049 [TBL] [Abstract][Full Text] [Related]
22. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery. Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331 [TBL] [Abstract][Full Text] [Related]
23. Comparison of oral aspirin versus topical applied methyl salicylate for platelet inhibition. Tanen DA; Danish DC; Reardon JM; Chisholm CB; Matteucci MJ; Riffenburgh RH Ann Pharmacother; 2008 Oct; 42(10):1396-401. PubMed ID: 18698012 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin. Kreutz RP; Nystrom P; Kreutz Y; Miao J; Kovacs R; Desta Z; Flockhart DA; Jin Y Platelets; 2013; 24(2):145-50. PubMed ID: 22385219 [TBL] [Abstract][Full Text] [Related]
25. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement. Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279 [TBL] [Abstract][Full Text] [Related]
26. Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance? Payne DA; Jones CI; Hayes PD; Webster SE; Ross Naylor A; Goodall AH Thromb Haemost; 2004 Jul; 92(1):89-96. PubMed ID: 15213849 [TBL] [Abstract][Full Text] [Related]
27. Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease. Malinin AI; Atar D; Callahan KP; McKenzie ME; Serebruany VL Eur J Pharmacol; 2003 Feb; 462(1-3):139-43. PubMed ID: 12591106 [TBL] [Abstract][Full Text] [Related]
28. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1. Faraday N; Yanek LR; Mathias R; Herrera-Galeano JE; Vaidya D; Moy TF; Fallin MD; Wilson AF; Bray PF; Becker LC; Becker DM Circulation; 2007 May; 115(19):2490-6. PubMed ID: 17470694 [TBL] [Abstract][Full Text] [Related]
29. Population pharmacodynamic modelling of aspirin- and Ibuprofen-induced inhibition of platelet aggregation in healthy subjects. Hong Y; Gengo FM; Rainka MM; Bates VE; Mager DE Clin Pharmacokinet; 2008; 47(2):129-37. PubMed ID: 18193919 [TBL] [Abstract][Full Text] [Related]
30. Anti-platelet effect of aspirin is substantially reduced after administration of heparin during carotid endarterectomy. Webster SE; Payne DA; Jones CI; Hayes PD; Bell PR; Goodall AH; Naylor AR J Vasc Surg; 2004 Sep; 40(3):463-8. PubMed ID: 15337874 [TBL] [Abstract][Full Text] [Related]
31. The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidine. Farrell TP; Hayes KB; Sobel BE; Schneider DJ Am J Cardiol; 1999 Mar; 83(5):770-4. PubMed ID: 10080435 [TBL] [Abstract][Full Text] [Related]
32. 2-arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors. Keown OP; Winterburn TJ; Wainwright CL; Macrury SM; Neilson I; Barrett F; Leslie SJ; Megson IL Br J Clin Pharmacol; 2010 Aug; 70(2):180-8. PubMed ID: 20653671 [TBL] [Abstract][Full Text] [Related]
35. Human platelet alphaIIbeta3 integrin binding affinity and specificity of SJ874: antiplatelet efficacy versus aspirin. Mousa SA; Forsythe M; Bozarth J; Jin F; Confalone PN Coron Artery Dis; 2000 Oct; 11(7):563-70. PubMed ID: 11023245 [TBL] [Abstract][Full Text] [Related]
36. Platelet aggregation in response to ADP is highly variable in normal donors and patients on anti-platelet medication. Dunne E; Egan K; McFadden S; Foley D; Kenny D Clin Chem Lab Med; 2016 Jul; 54(7):1269-73. PubMed ID: 26562035 [TBL] [Abstract][Full Text] [Related]
37. Effect of obesity on platelet reactivity and response to low-dose aspirin. Bordeaux BC; Qayyum R; Yanek LR; Vaidya D; Becker LC; Faraday N; Becker DM Prev Cardiol; 2010; 13(2):56-62. PubMed ID: 20377806 [TBL] [Abstract][Full Text] [Related]
38. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man. May JA; Heptinstall S; Cole AT; Hawkey CJ Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371 [TBL] [Abstract][Full Text] [Related]
39. Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors. Salama MM; Morad AR; Saleh MA; Sabri NA; Zaki MM; ElSafady LA J Clin Pharm Ther; 2012 Dec; 37(6):630-6. PubMed ID: 23121257 [TBL] [Abstract][Full Text] [Related]
40. Why single daily dose of aspirin may not prevent platelet aggregation. Altman R; Scazziota A; Funes JC Thromb Res; 1988 Aug; 51(3):259-66. PubMed ID: 3140408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]